Serving the growing biotechnology community

The Latest News from BioAgilytix

11 June, 2019

BioAgilytix Welcomes Sean Blake to Leadership Team as Chief Information Officer

In this role, Mr. Blake will lead the development, assessment, and execution of critical IT strategies across BioAgilytix’s international operations to support the company’s continued growth and position as a technologically-advanced bioanalytical services provider.

Read More

1 January, 2019

BioAgilytix Announces Several Promotions within Its Leadership Team

BioAgilytix has announced several promotions within its leadership team. PD Dr. Arno Kromminga has been promoted to Global Chief Scientific Officer, and will lead BioAgilytix’s global scientific strategy while also continuing to serve as the European Managing Director. Beth Heinz has been promoted to Vice President of Global Business Development and will continue her focus on cultivating and managing both strong client relationships and strategic partnerships worldwide.

Read More

6 November, 2018

Cobepa plant vlag in Amerikaanse farma

De Belgische investeringsmaatschappij Cobepa koopt BioAgilytix, een Amerikaans bedrijf dat testen uitvoert voor de farma- en biotechsector. Het is de tweede deal van Cobepa in de VS.

Read More

6 November, 2018

Riverside Partners to Score 7.4-Times Return on BioAgilytix

Riverside Partners is set to earn a lofty return from its sale of BioAgilytix Labs LLC, a Durham, N.C.-based provider of molecular bioanalysis services. The Boston firm is expected to earn a 7.4-times money-on-money return and an internal rate of return of about 50% on the sale, according to a person familiar with the matter. The sale is expected to return half of the invested capital from Riverside’s $561 million fifth fund, or about $280 million, the person said.

Read More

5 November, 2018

BioAgilytix CEO talks strategy after buyout: ‘You’ll be seeing us make acquisitions’

Bioagilytix, a 2018 Triangle Business Journal Fast 50 Awards winner, will have even more wind blowing into its sails as the company is about to be acquired by a Belgium firm.

Read More

5 November, 2018

Belgian investment company acquires Durham biotesting firm BioAgilytix

Durham-based BioAgilytix, a fast-growing provider of bioanalytical testing services for large-molecule drugs, will be acquired by a privately held Belgian investment company. The acquisition will provide BioAgilytix with increased capital and resources to meet growing demand for its services, said Jim Datin, president and chief executive officer, who also serves on the North Carolina Biotechnology Center’s board of directors.

Read More

2 November, 2018

Durham’s BioAgilytix to be acquired by European investment firm

BioAgilytix is on the verge of being acquired by an international firm that is expected to bring a lot more money into the expanding company’s portfolio. The Durham-based company announced that Cobepa S.A. a private, Brussels-based investment company will close a deal acquiring the company later this month. Financial details of the deal have not been disclosed.

Read More

2 November, 2018

BioAgilytix to be Acquired by Private Investment Company Cobepa

BioAgilytix has announced an agreement to be acquired by Cobepa S.A., a privately-held investment company. The acquisition by Cobepa will provide BioAgilytix with increased funding and resources to meet growing demand for its high-quality services, driven by its strong scientific reputation and leading expertise in biologics development.

Read More

3 October, 2018

BioAgilytix Recognized as a Triangle Business Journal 2018 Fast 50 Winner

BioAgilytix has been named as one of Triangle Business Journal’s Fast 50 Award winners for 2018. This award is designed to honor those privately held companies in the Triangle Park area that have demonstrated remarkable growth in the past three years.

Read More